Marion Laboratories Inc's stock rise sharply company present bullish earnings scenario meeting pharmaceutical analyst Monday trader analyst said. The company expect earnings fiscal 1987 end June 30 rise 75 pct ago. That pronouncement encourage analyst David Crossen Sanford C. Bernstein Co raise earnings estimate company 1.28 dlrs share 1987 compare previous estimate 1.20 dlrs share. Last company earn 70 ct share. Marion's stock gain 3-1/4 75-1/2. At meeting pharmaceutical analyst Marion's president Fred Lyons Jr. Wall Street eanrings estimate 1.10-1.15 dlrs share fiscal 1987 "are expect cause aggressive range 10 15 ct low." Lyons strong performance half result fourth quarter introduction 90 mg 120 mg Cardizem tablets. Analyst Crossen Cardizem treat angina expect approve treatment hypertension year. Crossen "because Marion company growth Cardizem have impact bottom line." He raise fiscal 1988 earnings estimate 2.15 dlrs share previous estimate 2.05 dlrs share. "The company broad product pipeline industry I be concerned innovative company business" said. For five 1991 Crossen expect Marion growth rate 55 pct. Reuter 